Midostaurin Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: CGP 41251, CGP41251, N-Benzoyl-Staurosporine, N-Benzoylstaurosporine, PKC-412 +2 more

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Richard Stone, MD1
M.D. Anderson Cancer Center1

Indications

Acute Myeloid Leukemia2
Cancer2
AML With Gene Mutations1
Untreated Adult Acute Myeloid Leukemia1
de Novo Myelodysplastic Syndrome1

New Haven, Connecticut1 trial

Revumenib in Combination With 7+3 + Midostaurin in AML

Yale Cancer Center

Phase 1

Houston, Texas1 trial

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.